SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-013031
Filing Date
2024-04-03
Accepted
2024-04-03 17:00:32
Documents
14
Period of Report
2024-03-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 43835
  Complete submission text file 0001493152-24-013031.txt   269288

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20240326.xsd EX-101.SCH 3967
3 XBRL DEFINITION FILE bfri-20240326_def.xml EX-101.DEF 26984
4 XBRL LABEL FILE bfri-20240326_lab.xml EX-101.LAB 37236
5 XBRL PRESENTATION FILE bfri-20240326_pre.xml EX-101.PRE 25604
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6672
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40943 | Film No.: 24819811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)